Acute	acute	O	O	O	O
confusion	confusion	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
high-dose	high-dose	O	O	O	O
infusion	infusion	O	O	O	O
of	of	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
folinic	folinic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
61-year-old	61-year-old	O	O	O	O
man	man	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
combination	combination	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
incorporating	incorporating	O	O	O	O
cisplatinum	cisplatinum	O	O	OTHERS	I
,	,	O	O	O	O
etoposide	etoposide	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
high-dose	high-dose	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
2,250	2,250	O	O	O	O
mg/m2/24	mg/m2/24	O	O	O	O
hours	hours	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
folinic	folinic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
an	an	O	O	O	O
inoperable	inoperable	O	O	O	O
gastric	gastric	O	O	OTHERS	I
adenocarcinoma	adenocarcinoma	O	O	OTHERS	I
.	.	O	O	O	O

He	he	O	O	O	O
developed	developed	O	O	O	O
acute	acute	O	O	O	O
neurologic	neurologic	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
mental	mental	O	O	O	O
confusion	confusion	O	DISEASE	OTHERS	I
,	,	O	O	O	O
disorientation	disorientation	O	O	OTHERS	I
and	and	O	O	O	O
irritability	irritability	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
then	then	O	O	O	O
lapsed	lapsed	O	O	O	O
into	into	O	O	O	O
a	a	O	O	O	O
deep	deep	O	O	O	O
coma	coma	O	DISEASE	OTHERS	I
,	,	O	O	O	O
lasting	lasting	O	O	O	O
for	for	O	O	O	O
approximately	approximately	O	O	O	O
40	40	O	O	O	O
hours	hours	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
dose	dose	O	O	O	O
(	(	O	O	O	O
day	day	O	O	O	O
2	2	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
folinic	folinic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
complication	complication	O	O	O	O
reappeared	reappeared	O	O	O	O
on	on	O	O	O	O
day	day	O	O	O	O
25	25	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
second	second	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
folinic	folinic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
were	were	O	O	O	O
then	then	O	O	O	O
the	the	O	O	O	O
only	only	O	O	O	O
drugs	drugs	O	O	O	O
given	given	O	O	O	O
.	.	O	O	O	O

Because	because	O	O	O	O
folinic	folinic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
unlikely	unlikely	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
this	this	O	O	O	O
condition	condition	O	O	O	O
,	,	O	O	O	O
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
high-dose	high-dose	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
highly	highly	O	O	O	O
suspected	suspected	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
pathogenesis	pathogenesis	O	O	O	O
of	of	O	O	O	O
5-fluorouracil	5-fluorouracil	CHEMICALS	O	OTHERS	I
neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
Krebs	krebs	O	O	O	O
cycle	cycle	O	O	O	O
blockade	blockade	O	O	O	O
by	by	O	O	O	O
fluoroacetate	fluoroacetate	O	O	OTHERS	I
and	and	O	O	O	O
fluorocitrate	fluorocitrate	O	O	OTHERS	I
,	,	O	O	O	O
thiamine	thiamine	O	DISEASE	OTHERS	I
deficiency	deficiency	O	DISEASE	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
dihydrouracil	dihydrouracil	O	O	OTHERS	I
dehydrogenase	dehydrogenase	O	O	O	O
deficiency	deficiency	O	O	O	O
.	.	O	O	O	O

High-dose	high-dose	O	O	O	O
5-fluorouracil/folinic	5-fluorouracil/folinic	O	O	O	O
acid	acid	O	O	O	O
infusion	infusion	O	O	O	O
therapy	therapy	O	O	O	O
has	has	O	O	O	O
recently	recently	O	O	O	O
become	become	O	O	O	O
a	a	O	O	O	O
popular	popular	O	O	O	O
regimen	regimen	O	O	O	O
for	for	O	O	O	O
various	various	O	O	O	O
cancers	cancers	O	DISEASE	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
necessary	necessary	O	O	O	O
that	that	O	O	O	O
both	both	O	O	O	O
oncologists	oncologists	O	O	O	O
and	and	O	O	O	O
neurologists	neurologists	O	O	O	O
be	be	O	O	O	O
fully	fully	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
unusual	unusual	O	O	O	O
complication	complication	O	O	O	O
.	.	O	O	O	O

